Heart-Pak trials to begin in home patients:
This article was originally published in Clinica
Thermo Cardiosystems is to begin testing its HeartPak portable driver in patients' homes. The compact, battery-powered device provides an external source of power for the company's pneumatic HeartMate left ventricular-assist system (LVAS) and is specifically designed for home use. It is already available in Europe and Asia. The HeartMate system, which acts as a bridge to heart transplant, was approved by the FDA in 1994.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.